| __timestamp | Pharming Group N.V. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 54823000000 |
| Thursday, January 1, 2015 | 5247851 | 76691000000 |
| Friday, January 1, 2016 | 4925118 | 87477000000 |
| Sunday, January 1, 2017 | 14930297 | 89052000000 |
| Monday, January 1, 2018 | 25371768 | 100745000000 |
| Tuesday, January 1, 2019 | 23921274 | 91915000000 |
| Wednesday, January 1, 2020 | 25338236 | 95905000000 |
| Friday, January 1, 2021 | 20182966 | 104442000000 |
| Saturday, January 1, 2022 | 17562000 | 104437000000 |
| Sunday, January 1, 2023 | 25212000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical and retail landscape, Walgreens Boots Alliance, Inc. and Pharming Group N.V. present a fascinating study in contrasts. Over the past decade, Walgreens has consistently demonstrated a robust cost of revenue, peaking at approximately $112 billion in 2023, a 104% increase from 2014. This reflects its expansive retail operations and strategic acquisitions. In contrast, Pharming Group N.V., a smaller player, has shown a more volatile trend, with its cost of revenue fluctuating significantly, reaching a high of around $25 million in 2023. This variability underscores the challenges faced by niche biotech firms in scaling operations. Notably, the data for 2024 is incomplete, highlighting the dynamic nature of these industries. As these companies navigate the complexities of global markets, their financial trajectories offer valuable insights into their strategic priorities and operational efficiencies.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Novo Nordisk A/S and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Mesoblast Limited
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses